Stephen G. Nuara
Montreal, QC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Concurrent mGlu2-mGlu4 receptor positive allosteric modulation for L-DOPA-induced treatment-induced complications in the parkinsonian marmoset.
Journal: Pharmacology, biochemistry, and behavior
Published: December 14, 2025
Effect of the mGlu2 receptor positive allosteric modulator AZD8529 on L-DOPA-induced dyskinesia and psychosis-like behaviours in the parkinsonian marmoset.
Journal: European journal of pharmacology
Published: April 11, 2025
Positive allosteric mGluR2 modulation with BINA alleviates dyskinesia and psychosis-like behaviours in the MPTP-lesioned marmoset.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: April 09, 2024
Effect of mGluR2 and mGluR2/3 activators on parkinsonism in the MPTP-lesioned non-human primate.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: March 21, 2024
Effect of the mGlu2 positive allosteric modulator biphenyl-indanone A as a monotherapy and as adjunct to a low dose of L-DOPA in the MPTP-lesioned marmoset.
Journal: The European journal of neuroscience
Published: January 18, 2024
Effect of the mGlu4 positive allosteric modulator ADX-88178 on parkinsonism, psychosis-like behaviours and dyskinesia in the MPTP-lesioned marmoset.
Journal: Psychopharmacology
Published: April 20, 2023
The 5-HT2A/2C inverse agonist nelotanserin alleviates L-DOPA-induced dyskinesia in the MPTP-lesioned marmoset.
Journal: The European journal of neuroscience
Published: April 19, 2023
Distribution of [11C]-JNJ-42491293 in the marmoset brain: a positron emission tomography study.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: January 05, 2023
Anti-parkinsonian effect of the mGlu2 positive allosteric modulator LY-487,379 as monotherapy and adjunct to a low L-DOPA dose in the MPTP-lesioned marmoset.
Journal: European journal of pharmacology
Published: September 26, 2022
The mGluR2/3 orthosteric agonist LY-404,039 reduces dyskinesia, psychosis-like behaviours and parkinsonism in the MPTP-lesioned marmoset.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: September 14, 2022
Evaluation of the effects of the mGlu2/3 antagonist LY341495 on dyskinesia and psychosis-like behaviours in the MPTP-lesioned marmoset.
Journal: Pharmacological reports : PR
Published: March 26, 2022
Additive effects of mGluR2 positive allosteric modulation, mGluR2 orthosteric stimulation and 5-HT2AR antagonism on dyskinesia and psychosis-like behaviours in the MPTP-lesioned marmoset.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: July 12, 2021
Last Updated: 09/26/2026